|
Finch Therapeutics Group, Inc. (FNCH) DCF Valoración
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Finch Therapeutics Group, Inc. (FNCH) Bundle
¡Evalúe las perspectivas financieras de Finch Therapeutics Group, Inc. (FNCH) con precisión experta! Esta calculadora DCF (FNCH) proporciona datos financieros preconidos, al tiempo que le ofrece la flexibilidad de modificar el crecimiento de los ingresos, WACC, los márgenes y otros supuestos esenciales para alinearse con sus predicciones.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.2 | 7.7 | 18.5 | .9 | .1 | .1 | .1 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | -23.98 | 140.08 | -95.35 | -87.57 | -26.73 | -26.73 | -26.73 | -26.73 | -26.73 |
| EBITDA | -20.7 | -38.6 | -57.7 | -82.7 | -32.5 | -.1 | -.1 | .0 | .0 | .0 |
| EBITDA, % | -203.47 | -500.66 | -311.27 | -9603.6 | -30357.01 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .5 | .8 | 2.3 | 5.5 | 1.5 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 4.75 | 10.23 | 12.42 | 639.61 | 1420.56 | 45.48 | 45.48 | 45.48 | 45.48 | 45.48 |
| EBIT | -21.1 | -39.4 | -60.0 | -88.2 | -34.0 | -.1 | -.1 | .0 | .0 | .0 |
| EBIT, % | -208.21 | -510.9 | -323.68 | -10243.21 | -31777.57 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 42.2 | 99.7 | 133.5 | 71.0 | 25.1 | .1 | .1 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4.7 | 1.1 | .5 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 46.74 | 14.19 | 2.67 | 16.72 | 0 | 16.06 | 16.06 | 16.06 | 16.06 | 16.06 |
| Inventories | .0 | .0 | -9.1 | -3.5 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0.000009848336 | 0 | -48.94 | -408.01 | 0 | -29.79 | -29.79 | -29.79 | -29.79 | -29.79 |
| Accounts Payable | .7 | 2.6 | 3.7 | 1.1 | .1 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 6.45 | 33.96 | 20.17 | 127.41 | 131.78 | 52.11 | 52.11 | 52.11 | 52.11 | 52.11 |
| Capital Expenditure | -1.0 | -2.6 | -16.0 | -2.2 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -9.9 | -34.11 | -86.25 | -253.43 | 0 | -46.05 | -46.05 | -46.05 | -46.05 | -46.05 |
| Tax Rate, % | 4.42 | 4.42 | 4.42 | 4.42 | 4.42 | 4.42 | 4.42 | 4.42 | 4.42 | 4.42 |
| EBITAT | -20.8 | -39.3 | -57.6 | -87.5 | -32.5 | -.1 | -.1 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -25.4 | -35.6 | -60.5 | -92.0 | -35.3 | -.2 | -.1 | -.1 | .0 | .0 |
| WACC, % | 6.71 | 6.75 | 6.65 | 6.74 | 6.64 | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | -1 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | 5 | |||||||||
| Equity Value | -6 | |||||||||
| Diluted Shares Outstanding, MM | 2 | |||||||||
| Equity Value Per Share | -3.58 |
What You Will Get
- Real Finch Therapeutics Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Finch Therapeutics' fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- Comprehensive Financial Data: Access accurate pre-loaded historical data and future projections specific to Finch Therapeutics Group, Inc. (FNCH).
- Tailored Forecast Assumptions: Modify yellow-highlighted cells such as WACC, growth rates, and profit margins to fit your analysis.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow evaluations.
- Interactive Dashboard: User-friendly charts and summaries to effectively visualize your valuation outcomes.
- Designed for All Users: A straightforward, intuitive layout suitable for investors, CFOs, and consultants alike.
How It Works
- Download: Obtain the ready-to-use Excel file featuring Finch Therapeutics Group, Inc. (FNCH) financial data.
- Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to suit your analysis.
- Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various projections and instantly compare the results.
- Make Decisions: Leverage the valuation insights to inform your investment choices.
Why Choose This Calculator?
- Designed for Experts: A specialized tool utilized by researchers, financial analysts, and biopharma consultants.
- Comprehensive Data: Finch Therapeutics' historical and projected financials preloaded for precise analysis.
- Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Transparent Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth calculation process.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for assessing Finch Therapeutics Group, Inc. (FNCH) investments.
- Biotech Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Finch Therapeutics Group, Inc. (FNCH).
- Students and Educators: Utilize real-time data to practice and teach financial modeling in the biotech sector.
- Life Sciences Enthusiasts: Gain insights into how biotech companies like Finch Therapeutics Group, Inc. (FNCH) are valued in the market.
What the Template Contains
- Historical Data: Includes Finch Therapeutics Group’s past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Finch Therapeutics Group’s intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Finch Therapeutics Group’s financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.